Drug for treating asthma and preparation method thereof

Abstract

The invention relates to a drug for treating asthma and a preparation method thereof. The drug is prepared from the following traditional Chinese medicine as active pharmaceutical ingredients in partsby weight: ginkgo nuts, snakegourd peel, radix ophiopogonis, wolfberry, black soybeans, bamboo shavings, exocarpium citri rubrum, semen armeniacae amarae, folium perillae, fructus schisandrae chinensis, herba ephedra, bulbus fritillariae ussuriensis, betel nut, smoked plum pulp, radix peucedani, rhizoma pinelliae preparatum, pine pollen, rhizoma anemarrhenae, raw gypsum, fructus chebulae, bulbusallii macrostemonis, herba asari, rhizoma belamcandae and radix glycyrrhizae preparata. The preparation method comprises the following steps: putting folium perillae, semen armeniacae amarae, ginkgo nuts and black soybeans into an extracting tank, and extracting filtrate; concentrating the filtrate so as to obtain an extract, and drying the extract by virtue of a microwave drying machine; sterilizing, drying and mixing the other components, crushing the mixture and the dried extract by virtue of an ultrafine powder crushing machine, and mixing medical powder, so as to obtain pharmaceutical active components; and preparing the active pharmaceutical ingredients into the drug in required dose form by virtue of a conventional method. The active pharmaceutical ingredients of the drug can supplement each other, so that the treatment effect of the drug can be enhanced, untoward effects can be reduced, and asthma can be fundamentally treated.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a medicine for treating asthma, and also relates to a preparation method of the medicine. Background technique [0002] Asthma is a common respiratory disease that can occur at any age, but more than half of them begin before the age of 12, and the incidence rate of adults and men is roughly the same. There are about 100 million people with bronchial asthma in the world. Bronchial asthma is a common and frequently-occurring disease, which is composed of various cells (such as eosinophils, mast cells, T cells, airway epithelial cells, etc.) and cell components. Chronic inflammatory diseases of the airways, according to WHO statistics, the number of asthma patients worldwide reaches 275 million, and more than 180,000 people die of asthma every year. In the past 10 years, the morbidity and mortality of asthma have continued to rise. The incidence rate of asthma in my ...

AI Technical Summary

Problems solved by technology

The above western medicine treatment can relieve the symptoms, but it does not treat the cause of asthma, which makes the asthma attack repeatedly and becomes dependent on drugs, which affects the normal life of asthma patients. At the same time, because of the side effects of western medicine, asthma patients cannot do strenuous exercise , not being able to exercise, which ends up causing other health problems